The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline-concordant lung cancer staging.
lung neoplasms
mediastinal staging
neoplasm staging
non–small cell lung cancer
quality improvement
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
30 Sep 2024
30 Sep 2024
Historique:
medline:
30
9
2024
pubmed:
30
9
2024
entrez:
30
9
2024
Statut:
aheadofprint
Résumé
Accurate staging improves lung cancer survival by increasing the chances of delivering stage-appropriate therapy. However, there is underutilization of, and variability in, the use of guideline-recommended diagnostic tests used to stage lung cancer. Consequently, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) convened the Triage for Appropriate Treatment Task Group-a multidisciplinary expert and stakeholder panel-to identify knowledge and/or resource gaps contributing to guideline-discordant staging and make recommendations to overcome these gaps. The task group determined the following: Gap 1: facilitators of and barriers to guideline-concordant staging are incompletely understood; Recommendation 1: identify facilitators of and barriers to guideline-concordant lung cancer staging; Gap 2: the level of evidence supporting staging algorithms is low-to-moderate; Recommendation 2: prioritize comparative-effectiveness studies evaluating lung cancer staging; Gap 3: guideline recommendations vary across professional societies; Recommendation 3: harmonize guideline recommendations across professional societies; Gap 4: existing databases do not contain sufficient information to measure guideline-concordant staging; Recommendation 4: augment existing databases with the information required to measure guideline-concordant staging; Gap 5: health systems do not have a performance feedback mechanism for lung cancer staging; Recommendation 5: develop and implement a performance feedback mechanism for lung cancer staging; Gap 6: patients rarely self-advocate for guideline-concordant staging; Recommendation 6: increase opportunities for patient self-advocacy for guideline-concordant staging; and Gap 7: current health policies do not motivate guideline-concordant lung cancer staging; Recommendation 7: organize a representative working group under the ACS NLCRT that promotes policies that motivate guideline-concordant lung cancer staging. PLAIN LANGUAGE SUMMARY: Staging-determining the degree of cancer spread-is important because it helps clinicians choose the best cancer treatment. Receiving the best cancer treatment leads to the best possible patient outcomes. Practice guidelines are intended to help clinicians stage patients with lung cancer. However, lung cancer staging in the United States often varies from practice guideline recommendations. This report identifies seven opportunities to improve lung cancer staging.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : American Cancer Society National Lung Cancer Roundtable
Informations de copyright
© 2024 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
US Department of Health and Human Services. The Health Consequences of Smoking‐‐50 Years of Progress: A Report of the Surgeon General. Public Health Service. https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf. Published 2014. Accessed September 10, 2021.
Jeon J, Holford TR, Levy DT, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065: a comparative modeling approach. Ann Intern Med. 2018;169(10):684‐693. doi:10.7326/m18‐1250
Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975‐2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100(23):1672‐1694. doi:10.1093/jnci/djn389
de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung‐cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503‐513. doi:10.1056/nejmoa1911793
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung‐cancer mortality with low‐dose computed tomographic screening. N Engl J Med. 2011;365(5):395‐409. doi:10.1056/nejmoa1102873
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung‐cancer treatment on population mortality. N Engl J Med. 2020;383(7):640‐649. doi:10.1056/nejmoa1916623
Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non–small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest. 2013;143(5 Suppl):e211S‐e250S. doi:10.1378/chest.12‐2355
Non‐Small Cell Lung Cancer, Version 4.2021, National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed April 24, 2021.
Backhus LM, Farjah F, Varghese TK, et al. Appropriateness of imaging for lung cancer staging in a national cohort. J Clin Oncol. 2014;32(30):3428‐3435. doi:10.1200/jco.2014.55.6589
Mazzone PJ, Vachani A, Chang A, et al. Quality indicators for the evaluation of patients with lung cancer. Chest. 2014;146(3):659‐669. doi:10.1378/chest.13‐2900
Verdial FC, Madtes DK, Hwang B, et al. Prediction model for nodal disease among patients with non‐small cell lung cancer. Ann Thorac Surg. 2019;107(6):1600‐1606. doi:10.1016/j.athoracsur.2018.12.041
Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non–small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253‐260. doi:10.1016/j.lungcan.2007.03.012
Krantz SB, Howington JA, Wood DE, et al. Invasive mediastinal staging for lung cancer by The Society of Thoracic Surgeons database participants. Ann Thorac Surg. 2018;106(4):1055‐1062. doi:10.1016/j.athoracsur.2018.05.012
Vest MT, Tanoue L, Soulos PR, et al. Thoroughness of mediastinal staging in stage IIIA non–small cell lung cancer. J Thorac Oncol. 2012;7(1):188‐195. doi:10.1097/jto.0b013e318236ecbb
Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest. 2020;157(5):1322‐1345. doi:10.1016/j.chest.2019.09.025
Osarogiagbon RU, Lee YS, Faris NR, Ray MA, Ojeabulu PO, Smeltzer MP. Invasive mediastinal staging for resected non–small cell lung cancer in a population‐based cohort. J Thorac Cardiovasc Surg. 2019;158(4):1220‐1229. e1222. doi:10.1016/j.jtcvs.2019.04.068
Osarogiagbon RU, Yu X. Nonexamination of lymph nodes and survival after resection of non–small cell lung cancer. Ann Thorac Surg. 2013;96(4):1178‐1189. doi:10.1016/j.athoracsur.2013.05.021
Navani N, Fisher DJ, Tierney JF, et al. The accuracy of clinical staging of stage I‐IIIa non‐small cell lung cancer: an analysis based on individual participant data. Chest. 2019;155(3):502‐509. doi:10.1016/j.chest.2018.10.020
Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early‐stage lung cancer. N Engl J Med. 1999;341(16):1198‐1205. doi:10.1056/nejm199910143411606
Gould MK, Schultz EM, Wagner TH, et al. Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011;6(5):875‐883. doi:10.1097/jto.0b013e31821671b6
Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non‐small‐cell lung cancer. J Clin Oncol. 2006;24(3):413‐418. doi:10.1200/jco.2005.02.1758
Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat Blacks and Whites. N Engl J Med. 2004;351(6):575‐584. doi:10.1056/nejmsa040609
National Lung Cancer Roundtable. https://nlcrt.org/. Accessed August 27, 2021.
Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol. 2001;19(11):2886‐2897. doi:10.1200/jco.2001.19.11.2886
Brouwers MC, Makarski J, Garcia K, et al. A mixed methods approach to understand variation in lung cancer practice and the role of guidelines. Implement Sci. 2014;9(1):36. doi:10.1186/1748‐5908‐9‐36
Detterbeck F. What is quality and does it matter? J Thorac Oncol. 2009;4(3):279‐280. doi:10.1097/jto.0b013e3181989be5
Kwon DH, Tisnado DM, Keating NL, et al. Physician‐reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction. Cancer. 2015;121(1):113‐122. doi:10.1002/cncr.29019
Henderson LM, Farjah F, Detterbeck F, Smith RA, Silvestri GA, Rivera MP. Pretreatment invasive nodal staging in lung cancer: knowledge, attitudes, and beliefs among academic and community physicians. Chest. 2021;161(3):826‐832. doi:10.1016/j.chest.2021.11.010
Massard G, Antonoff MB, Noel JL, et al. Transatlantic editorial: thoracic surgeons need recognition of competence in thoracic oncology. Ann Thorac Surg. 2017;104(4):1103‐1107. doi:10.1016/j.athoracsur.2017.04.068
Tanner NT, Pastis NJ, Silvestri GA. Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest. 2013;143(2):423‐428. doi:10.1378/chest.12‐0212
Chest. GAIN NSCLC Summit: https://www.chestnet.org/Store/Products/Events/2017/NonSmall‐Cell‐Lung‐Cancer‐GAIN‐Handson‐Summit‐San‐Francisco‐CA‐Mar‐2017. Published 2017. Accessed September 13, 2021.
Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET‐CT. N Engl J Med. 2009;361(1):32‐39. doi:10.1056/nejmoa0900043
Annema JT, van Meerbeeck JP, Rintoul RC, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA. 2010;304(20):2245‐2252. doi:10.1001/jama.2010.1705
Farjah F, Wood DE. Counterpoint: should ultrasonographic endoscopy be the preferred modality for staging of lung cancer? No. Chest. 2014;145(3):449‐451. doi:10.1378/chest.13‐2724
Farjah F, Silvestri GA, Wood DE. Commentary: invasive mediastinal staging for lung cancer‐quality gap, evidence gap, both? J Thorac Cardiovasc Surg. 2019;158(4):1232‐1233. doi:10.1016/j.jtcvs.2019.05.016
Schuler MS, Rose S. Targeted maximum likelihood estimation for causal inference in observational studies. Am J Epidemiol. 2017;185(1):65‐73. doi:10.1093/aje/kww165
Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W. A formal risk‐benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med. 2010;12(11):686‐693. doi:10.1097/gim.0b013e3181eff533
Wahidi MM, Ernst A. Point: should ultrasonographic endoscopy be the preferred modality for staging of lung cancer? Yes. Chest. 2014;145(3):447‐449. doi:10.1378/chest.13‐2722
Thornblade LW, Wood DE, Mulligan MS, et al. Variability in invasive mediastinal staging for lung cancer: a multicenter regional study. J Thorac Cardiovasc Surg. 2018;155(6):2658‐2671:e2651. doi:10.1016/j.jtcvs.2017.12.138
Society of Thoracic Surgeons. General Thoracic Surgery Database Data Collection. https://www.sts.org/registries‐research‐center/sts‐national‐database/general‐thoracic‐surgery‐database/data‐collection. Accessed August 27, 2021.
Ross TR, Ng D, Brown JS, et al. The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration. EGEMS (Wash DC). 2014;2(1):1049. doi:10.13063/2327‐9214.1049
Farjah F. Comparative‐effectiveness of pretreament lung cancer nodal staging National Cancer Institute; 2022.
American College of Surgeons. ACS NSQIP Participant Use Data File. https://www.facs.org/quality‐programs/acs‐nsqip/participant‐use. Accessed August 20, 20212021.
American College of Radiology. Lung CT Screening Reporting & Data System (Lung‐RADS). https://www.acr.org/Clinical‐Resources/Reporting‐and‐Data‐Systems/Lung‐Rads. Accessed August 20, 2021.
College of American Pathologists. Cancer Protocols. https://www.cap.org/protocols‐and‐guidelines/cancer‐reporting‐tools/cancer‐protocols. Accessed August 23, 2021.
Ost DE, Ernst A, Lei X, et al. Diagnostic yield of endobronchial ultrasound‐guided transbronchial needle aspiration: results of the AQuIRE Bronchoscopy Registry. Chest. 2011;140(6):1557‐1566. doi:10.1378/chest.10‐2914
Ernst A, Simoff M, Ost D, Michaud G, Chandra D, Herth FJ. A multicenter, prospective, advanced diagnostic bronchoscopy outcomes registry. Chest. 2010;138(1):165‐170. doi:10.1378/chest.09‐2457
Nissen AP, Vreeland TJ, Teshome M, et al. American College of Surgeons Commission on Cancer Standard for Curative‐intent Pulmonary Resection. Ann Thorac Surg. 2022;113(1):5‐8. doi:10.1016/j.athoracsur.2021.05.051
Loudon K, Santesso N, Callaghan M, et al. Patient and public attitudes to and awareness of clinical practice guidelines: a systematic review with thematic and narrative syntheses. BMC Health Serv Res. 2014;14(1):321. doi:10.1186/1472‐6963‐14‐321
National Comprehensive Cancer Network. Patient and Caregiver Resources. https://www.nccn.org/patients/guidelines/cancers.aspx. Accessed August 27, 2021.